Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review

Medical Mycology Case Reports

Volumn 4, Issue 1, 2014, Pages 12-15

  Parcell, Benjamin J ^a   B C Raju, Pavan Kumar ^a   Johnson, Elizabeth M ^b   Fardon, Thomas C ^c   Olver, William J ^a  

^a NHS TAYSIDE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Anidulafungin; Aspergillus fumigatus; Extracorporeal membrane oxygenation support

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; C REACTIVE PROTEIN; CASPOFUNGIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; FLUCLOXACILLIN; FLUCONAZOLE; GAMMA INTERFERON; GENTAMICIN; IMMUNOGLOBULIN; ITRACONAZOLE; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; RIFAMPICIN; VORICONAZOLE;

ADULT; ALKALOSIS; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CHEST TUBE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIARRHEA; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; FEVER; HOSPITAL INFECTION; HUMAN; IATROGENIC DISEASE; IMMUNOTHERAPY; INFECTION PREVENTION; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LUNG ABSCESS; LUNG ASPERGILLOSIS; LUNG ASPIRATION; LUNG LAVAGE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATIENT TRANSPORT; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; THORAX DRAINAGE; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VIRUS PNEUMONIA;

EID: 84895815465     PISSN: 22117539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mmcr.2014.01.003     Document Type: Article

References (20)

1. C. Aubron, D. Pilcher, T. Leong, D.J. Cooper, C. Scheinkestel, and V. Pellegrino et al. Aspergillus sp. isolated in critically ill patients with extracorporeal membrane oxygenation support Scand J Infect Dis 45 9 2013 715 721
2. C. Aubron, A.C. Cheng, D. Pilcher, T. Leong, G. Magrin, and D.J. Cooper et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome Infect Control Hosp Epidemiol 34 1 2013 24 30
3. J.S. Burket, R.H. Bartlett, K. Vander Hyde, and C.E. Chenoweth Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation Clin Infect Dis 28 4 1999 828 833 (Pubitemid 29169423)
4. M.J. Bizzarro, S.A. Conrad, D.A. Kaufman, and P. Rycus Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults Pediatr Crit Care Med 12 13 2011 277 281
5. T.F. Patterson Aspergillus species G.L. Mandell, J.E. Bennett, R. Dolin, Principles and Practice of Infectious Diseases 2010 Churchill Livingstone Philadelphia 3241 3255
6. X. Garcia, A. Mian, P. Mendiratta, P. Gupta, P. Rycus, and P. Prodhan Aspergillus infection and extracorporeal membrane oxygenation support J Intensive Care Med 28 3 2013 178 184
7. M.S. Hsu, K.M. Chiu, Y.T. Huang, K.L. Kao, S.H. Chu, and C.H. Liao Risk factors for nosocomial infection during extracorporeal membrane oxygenation J Hosp Infect 73 3 2009 210 216
8. S.F. Marasco, G. Lukas, M. McDonald, J. McMillan, and B. Ihle Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients Heart Lung Circ 17 4 2008 S41 S47
9. J.M. O'Neill, G.E. Schutze, M.J. Heulitt, P.M. Simpson, and B.J. Taylor Nosocomial infections during extracorporeal membrane oxygenation Intensive Care Med 27 8 2001 1247 1253
10. B. De Pauw, T.J. Walsh, J.P. Donnelly, D.A. Stevens, J.E. Edwards, and T. Calandra et al. Revised deïnitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Co-operative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 12 2008 1813 1821
11. S.I. Blot, F.S. Taccone, A.M. Van den Abeele, P. Bulpa, W. Meersseman, and N. Brusselaers et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients Am J Respir Crit Care Med 186 1 2012 56 64
12. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr et al. Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America IDSA guidelines for aspergillosis Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
13. A. Upton, K.A. Kirby, P. Carpenter, M. Boeckh, and K.A. Marr Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality Clin Infect Dis 44 4 2007 531 540 (Pubitemid 46233255)
14. Marr K, Schlamm H, Rottinghaus ST, Jagannatha S, Bow EJ, Wingard JR., et al.A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis, abstr LB2812. Abstract. In: 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom; 2012.
15. D. Caillot, A. Thiebaut, R. Herbrecht, S. deBotton, A. Pigneux, and F. Bernard et al. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial) Cancer 110 12 2007 2740 2746 (Pubitemid 350250344)
16. A. Elefanti, J.W. Mouton, P.E. Verweij, A. Tsakris, L. Zerva, and J. Meletiadis Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: effect of serum on inhibitory and fungicidal interactions Antimicrob Agents Chemother 57 10 2013 4656 4663
17. S. Seyedmousavi, R.J. Brüggemann, W.J. Melchers, A.J. Rijs, P.E. Verweij, and J.W. Mouton Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis J Antimicrob Chemother 68 2 2013 385 393
18. D. Armstrong-James, I.A. Teo, S. Shrivastava, M.A. Petrou, D. Taube, and A. Dorling et al. Exogenous interferon gamma immunotherapy for invasive fungal infections in kidney transplant patients Am J Transplant 10 8 2010 1796 1803
19. C. Estrada, A.G. Desai, L.M. Chirch, H. Suh, R. Seidman, and F. Darras et al. Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma Case Rep Transplant 2012 2012 5 (Article ID 493758)
20. K. Al-Shair, G.T. Atherton, C. Harris, L. Ratcliffe, P.J. Newton, and D.W. Denning Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis Clin Infect Dis 57 6 2013 828 835